Illinois

Five-Year Summary: January 2017 to December 2021

Tables and graphs report on cancer screening and diagnostic services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the October 2022 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare award recipients’ results. Comparing data across award recipients is not advised due to extensive variation. For information on interpreting the data, refer to Screening Program Summaries.

Data for the following award recipients are suppressed: American Indian Cancer Foundation, the District of Columbia, Great Plains Tribal Chairmen's Health Board, Marshall Islands, and Massachusetts.

Program Overview

Women Served through the NBCCEDP
Category Number
Women served [1] 38,612
Women receiving cervical cancer screening and diagnostic services 17,876
Women receiving breast cancer screening and diagnostic services 34,700

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any screening or diagnostic procedure with services funded through the NBCCEDP.

Data source: October 2022 submission of NBCCEDP Minimum Data Elements (MDE) for Illinois.

Cervical Cancer Services

This pie chart illustrates the distribution of 17,876 women receiving NBCCEDP-funded cervical cancer services from January 2017 to December 2021 by race and ethnicity.

*Slices too small to view were combined into the Other Races slice (0.2%) and include: American Indian/Alaska Native (< 0.1%), Multiracial (0.1%), and Unknown (0.1%). Differences are due to rounding.

This pie chart illustrates the distribution of 17,876 women receiving NBCCEDP-funded cervical cancer services from January 2017 to December 2021 by age.

Cervical Results and Outcomes
Category Number
HPV tests provided 16,170
HPV tests with abnormal results [1] 3,572
Percentage of HPV tests with abnormal results 22.1
Pap tests provided 19,880
Pap tests with abnormal results [2] 1,740
Percentage of Pap tests with abnormal results 8.8
Age-adjusted percentage [3] 6.9
Cervical cancers or premalignant cervical lesions [4] 2,054
CIN1 or LSIL 1,479
CIN2 or worse [5] 575
Rate of CIN2 or worse detected per 1,000 Pap tests [5] 28.9
Age-adjusted rate per 1,000 Pap tests [3] 21.8

1: Abnormal HPV test results include: all positive high-risk HPV test results.

2: Abnormal Pap test results include: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

3: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

4: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, carcinoma in situ (CIS), and invasive cervical cancer.

5: Includes HSIL, CIN2, CIN3, CIS, and invasive cervical cancer.

Table includes HPV and Pap tests provided to women with services funded through the NBCCEDP. An additional 39 women, not included above, were diagnosed with LSIL, HSIL, CIN1, CIN2, CIN3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test with services funded through another source.

Breast Cancer Services

This pie chart illustrates the distribution of 34,700 women receiving NBCCEDP-funded breast cancer services from January 2017 to December 2021 by race and ethnicity.

*Slices too small to view were combined into the Other Races slice (0.3%) and include: American Indian/Alaska Native (0.1%), Multiracial (0.1%), and Unknown (0.1%).

This pie chart illustrates the distribution of 34,700 women receiving NBCCEDP-funded breast cancer services from January 2017 to December 2021 by age.

Breast Results and Outcomes
Category Number
Mammograms provided 50,141
Mammograms with abnormal results [1] 10,122
Percentage of mammograms with abnormal results 20.2
Age-adjusted percentage [2] 17.4
Breast cancers detected [3] 478
Rate of breast cancers detected per 1,000 mammograms 9.5
Age-adjusted rate per 1,000 mammograms [2] 10.7

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes mammograms provided to women age 40 and older with services funded through the NBCCEDP. Additionally, fewer than 16 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram with services funded through another source.